(Q48276896)

10 February 2018

title

Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration (English)

1 reference

10 February 2018

adaptive radiation therapy

main subject

0 references

author name string

Brada M

1

1 reference

10 February 2018

Sharpe G

2

1 reference

10 February 2018

Rajan B

3

1 reference

10 February 2018

Britton J

4

1 reference

10 February 2018

Wilkins PR

5

1 reference

10 February 2018

Guerrero D

6

1 reference

10 February 2018

Hines F

7

1 reference

10 February 2018

Traish D

8

1 reference

10 February 2018

Ashley S

9

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

10 February 2018

volume

43

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

287-292

1 reference

10 February 2018

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. A report from the MRC Working Party on misonidazole in gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Verbally administered Barthel Index as functional assessment in brain tumour patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Accelerated hyperfractionated radiotherapy for malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

Somnolence syndrome in adults following cranial irradiation for primary brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900390-3

7 January 2021

10.1016/S0360-3016(98)00390-3

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018